Read Fennec Pharmaceuticals Inc. R (RV41.MU) Q2 FY2026 earnings call transcript on Yahoo Finance to keep your investing strategy up to date with all of the latest information ...
Fennec Pharmaceuticals delivered a seventh consecutive quarter of growth, with Q2 2026 net product sales rising 78% year-over-year to $17.1 million and non-GAAP adjusted EBITDA turning positive at ...
As a reminder, today's conference call is being recorded. Now I'd like to turn the conference over to Fennec's Chief Financial Officer, Robert Andrade. Thank you, operator, and good morning, everyone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results